Concepedia

David M. Schwope

DM

Statistics

Publications

21

Citations

1.2K

H-Index

19

Active since

2009

Affiliations

National Institute on Drug Abuse(Current)

University of Maryland, Baltimore

National Institutes of Health

Sanofi (France)

AEgis Technologies (United States)

David M. Schwope is an author at National Institute on Drug Abuse specializing in cannabinoid pharmacology, medicine, and pharmacology.

Top concepts

Publications per year

2009–2023

21

Publications

21

Identification of Recent Cannabis Use: Whole-Blood and Plasma Free and Glucuronidated Cannabinoid Pharmacokinetics following Controlled Smoked Cannabis Administration

David M. Schwope, Erin L Karschner, David A. Gorelick et al. · Clinical Chemistry · 2011 · 184 citations · Full text

Δ9-Tetrahydrocannabinol (THC), 11-Hydroxy-THC, and 11-Nor-9-carboxy-THC Plasma Pharmacokinetics during and after Continuous High-Dose Oral THC

Eugene W Schwilke, David M. Schwope, Erin L Karschner et al. · Clinical Chemistry · 2009 · 114 citations · Full text

Psychomotor Performance, Subjective and Physiological Effects and Whole Blood  9-Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis

David M. Schwope, Wendy M. Bosker, Johannes G. Ramaekers et al. · Journal of Analytical Toxicology · 2012 · 100 citations · Full text

Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography–tandem mass spectrometry

David M. Schwope, Karl B. Scheidweiler, Marilyn A. Huestis · Analytical and Bioanalytical Chemistry · 2011 · 98 citations

, , +13

Tolerance to Effects of High-Dose Oral Δ9-Tetrahydrocannabinol and Plasma Cannabinoid Concentrations in Male Daily Cannabis Smokers

David A. Gorelick, Robert S. Goodwin, Eugene W Schwilke et al. · Journal of Analytical Toxicology · 2012 · 81 citations · Full text

Rows per page

1–5 of 21